Raising HDL-cholesterol through pharmacological inhibition of cholesteryl ester transfer protein is a potentially important strategy for prevention and treatment of cardiovascular diseases.
To use genetic variants in the CETP gene to assess potential risks and benefits of lifelong lower cholesteryl ester transfer protein activity on cardiovascular diseases and other outcomes.
A prospective biobank study, with 9-year foll...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's Version
- American Medical Association Publisher's website
- JAMA Cardiology Journal website
- Publication date:
- Acceptance date:
- Pubs id:
- Local pid:
- Copyright holder:
- Millwood et al.
- Copyright date:
- This is an open access article distributed under the terms of the CC-BY License. © 2017 Millwood IY et al. JAMA Cardiology.
CETP gene variants and risk of vascular and non-vascular diseases in ~150,000 Chinese adults
If you are the owner of this record, you can report an update to it here: Report update to this record